Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Remdesivir Reduced Mortality in Immunocompromised Patients Hospitalized for COVID-19 Across Variant Waves: Findings From Routine Clinical Practice
Essy Mozaffari, Aastha Chandak, Robert Gottlieb, et al.
Clinical Infectious Diseases (2023) Vol. 77, Iss. 12, pp. 1626-1634
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Remdesivir: A Review in COVID-19
Hannah A. Blair
Drugs (2023) Vol. 83, Iss. 13, pp. 1215-1237
Open Access | Times Cited: 35
Remdesivir for the Treatment of COVID-19: A Narrative Review
Patrick O. Godwin, Bryan Polsonetti, Michael F. Caron, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 1, pp. 1-19
Open Access | Times Cited: 13
COVID-19 therapeutics
Daniele Focosi, Massimo Franchini, Fabrizio Maggi, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 2
Closed Access | Times Cited: 13
National Institutes of Health COVID-19 Treatment Guidelines Panel: Perspectives and Lessons Learned
Roy M. Gulick, Alice K. Pau, Eric S. Daar, et al.
Annals of Internal Medicine (2024) Vol. 177, Iss. 11, pp. 1547-1557
Closed Access | Times Cited: 10
How Immunocompromised Hosts Were Left Behind in the Quest to Control the Covid-19 Pandemic
Michael Boeckh, Steven A. Pergam, Ajit P. Limaye, et al.
Clinical Infectious Diseases (2024)
Open Access | Times Cited: 9
Exploring FDA-Approved Antiviral Drugs for Human Metapneumovirus Treatment: Integrative Computational Insights
Amit Dubey, Manish Kumar, Aisha Tufail, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access | Times Cited: 1
Remdesivir Is Associated With Reduced Mortality in COVID-19 Patients Requiring Supplemental Oxygen Including Invasive Mechanical Ventilation Across SARS-CoV-2 Variants
Essy Mozaffari, Aastha Chandak, Robert Gottlieb, et al.
Open Forum Infectious Diseases (2023) Vol. 10, Iss. 10
Open Access | Times Cited: 15
Does early combination vs. Monotherapy improve clinical outcomes of clinically extremely vulnerable patients with COVID-19? Results from a retrospective propensity-weighted analysis
Maria Mazzitelli, Alberto Enrico Maraolo, Claudia Cozzolino, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 5
ORCHESTRA Delphi Consensus: Diagnostic and Therapeutic Management of SARS-CoV-2 Infection in Solid Organ Transplant Recipients
Beatrice Tazza, Natascia Caroccia, Alice Toschi, et al.
Clinical Microbiology and Infection (2025)
Closed Access
60-day mortality and the role of SARS-CoV-2 in hospital admissions of immunocompromised patients during later Omicron period: a population-based study in Sweden
Armin Sprečo, Christer Andersson, Rune Sjödahl, et al.
Infectious Diseases (2025), pp. 1-13
Open Access
Navigating Coronavirus Disease 2019 in Immunocompromised Populations
Majd Alsoubani, Jennifer Chow
Infectious Disease Clinics of North America (2025)
Closed Access
Remdesivir for the Treatment of COVID‐19 and Other Viral Infections with Pandemic Potential

(2025), pp. 333-364
Closed Access
COVID-19 infection is mild and has minimal impact on lung function in well vaccinated and widely treated lung transplant recipients
Samantha Ennis, Bronwyn Levvey, Helen V Shingles, et al.
The Journal of Heart and Lung Transplantation (2024) Vol. 43, Iss. 6, pp. 944-953
Closed Access | Times Cited: 2
Remdesivir is Associated with Reduced Mortality in Patients Hospitalized for COVID-19 Not Requiring Supplemental Oxygen
Essy Mozaffari, Aastha Chandak, Chidinma Chima-Melton, et al.
Open Forum Infectious Diseases (2024) Vol. 11, Iss. 6
Open Access | Times Cited: 2
Retrospective, Observational Analysis on the Impact of SARS-CoV-2 Variant Omicron in Hospitalized Immunocompromised Patients in a German Hospital Network—The VISAGE Study
Irit Nachtigall, Stefan Kwast, Sven Hohenstein, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 634-634
Open Access | Times Cited: 2
COVID-19 pneumonia in lung transplant recipients: understanding risk factors and treatment outcomes in Japan
Toshikazu Watanabe, Takashi Hirama, Miki Akiba, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
The winding road: Infectious disease considerations for CAR-T and other novel adoptive cellular therapies in the era of COVID-19
Kanal Singh, Joseph M. Rocco, Véronique Nussenblatt
Seminars in Hematology (2024) Vol. 61, Iss. 5, pp. 321-332
Closed Access | Times Cited: 2
Oral and intravenous 1'-cyano-substituted adenosine-like antivirals for early COVID-19
Robert Gottlieb, Roger Paredes
The Lancet Infectious Diseases (2023) Vol. 24, Iss. 2, pp. 108-110
Open Access | Times Cited: 4
Management of SARS-CoV-2 and Persistent Viral Detection in Solid Organ Transplant Recipients
Karen Larissa Pereira de Castro, Chetan Naik, Cedric W. Spak, et al.
Current Pulmonology Reports (2024) Vol. 13, Iss. 1, pp. 26-37
Open Access | Times Cited: 1
Treatment of patients hospitalized for COVID-19 with remdesivir is associated with lower likelihood of 30-day readmission: a retrospective observational study
Essy Mozaffari, Aastha Chandak, Robert Gottlieb, et al.
Journal of Comparative Effectiveness Research (2024) Vol. 13, Iss. 4
Open Access | Times Cited: 1
Antiviral treatment for SARS-CoV-2 infection in the current situation: a position paper of the Spanish Society of Emergency Medicine (SEMES)
Juan González del Castillo, Amparo Fernández-Simón Almela, Javier Jacob, et al.
Emergencias (2024)
Open Access | Times Cited: 1
Clinical outcomes and safety of remdesivir in hospitalized individuals with COVID-19, with or without severe renal impairment
Min‐Chi Chang, Ping‐Feng Wu, Yu-Chien Ho, et al.
Journal of Infection and Public Health (2024) Vol. 17, Iss. 7, pp. 102460-102460
Open Access | Times Cited: 1
Eco-Friendly Synchronous Spectrofluorimetric Method for Simultaneous Determination of Remdesivir and Acetyl Salicylic Acid in Spiked Human Plasma
Sohair mohamed aboelghar, Maha A. Hegazy, Hebatallah A. Wagdy
Journal of Fluorescence (2024)
Open Access | Times Cited: 1
Acute Respiratory Distress Syndrome in the Immunocompromised Patient
Nina Buchtele, Laveena Munshi
Clinics in Chest Medicine (2024) Vol. 45, Iss. 4, pp. 929-941
Closed Access | Times Cited: 1
Therapeutic strategy in the transplanted patient
María José Núñez-Orantos, Agustín Julián-Jiménez, Francisco Javier Candel, et al.
Revista Española de Quimioterapia (2023) Vol. 36, Iss. Suppl1, pp. 18-21
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top